Mark Parry has more than 16 years’ experience working within the pharmaceutical analysis and formulation development industry, with a particular focus on orally inhaled and nasal drug products. Mostly working in the pre-approval stages, his background includes extensive experience with product and formulation development for novel and generic products, as well as method development and validation, stability studies, pharmaceutical development activities, and clinical trial manufacturing for a wide range of clients.